These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 22819129)
1. Methoxetamine: from drug of abuse to rapid-acting antidepressant. Coppola M; Mondola R Med Hypotheses; 2012 Oct; 79(4):504-7. PubMed ID: 22819129 [TBL] [Abstract][Full Text] [Related]
2. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan. Lauterbach EC Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777 [TBL] [Abstract][Full Text] [Related]
3. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT Sayson LV; Botanas CJ; Custodio RJP; Abiero A; Kim M; Lee HJ; Kim HJ; Yoo SY; Lee KW; Ryu HW; Acharya S; Kim KM; Lee YS; Cheong JH Psychopharmacology (Berl); 2019 Jul; 236(7):2201-2210. PubMed ID: 30891619 [TBL] [Abstract][Full Text] [Related]
4. Methoxetamine: A foe or friend? Botanas CJ; de la Peña JB; Kim HJ; Lee YS; Cheong JH Neurochem Int; 2019 Jan; 122():1-7. PubMed ID: 30365979 [TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan as a potential rapid-acting antidepressant. Lauterbach EC Med Hypotheses; 2011 May; 76(5):717-9. PubMed ID: 21367535 [TBL] [Abstract][Full Text] [Related]
6. Is methoxydine a new rapid acting antidepressant for the treatment of depression in alcoholics? Coppola M; Mondola R Med Hypotheses; 2013 Jul; 81(1):10-4. PubMed ID: 23608163 [TBL] [Abstract][Full Text] [Related]
7. R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine. Botanas CJ; Perez Custodio RJ; Kim HJ; de la Pena JB; Sayson LV; Ortiz DM; Kim M; Lee HJ; Acharya S; Kim KM; Lee CJ; Ryu JH; Lee YS; Cheong JH Neuropharmacology; 2021 Aug; 193():108619. PubMed ID: 34023336 [TBL] [Abstract][Full Text] [Related]
8. [Ketamine for treatment of acute depression]. Hjerrild S; Bjerre J; Pedersen RH; Videbech P Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203 [TBL] [Abstract][Full Text] [Related]
9. Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Corazza O; Schifano F; Simonato P; Fergus S; Assi S; Stair J; Corkery J; Trincas G; Deluca P; Davey Z; Blaszko U; Demetrovics Z; Moskalewicz J; Enea A; di Melchiorre G; Mervo B; di Furia L; Farre M; Flesland L; Pasinetti M; Pezzolesi C; Pisarska A; Shapiro H; Siemann H; Skutle A; Enea A; di Melchiorre G; Sferrazza E; Torrens M; van der Kreeft P; Zummo D; Scherbaum N Hum Psychopharmacol; 2012 Mar; 27(2):145-9. PubMed ID: 22389078 [TBL] [Abstract][Full Text] [Related]
10. The ketamine analogue methoxetamine generalizes to ketamine discriminative stimulus in rats. Chiamulera C; Armani F; Mutti A; Fattore L Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):204-10. PubMed ID: 26866970 [TBL] [Abstract][Full Text] [Related]
11. Methoxetamine produces rapid and sustained antidepressant effects probably via glutamatergic and serotonergic mechanisms. Botanas CJ; Bryan de la Peña J; Custodio RJ; Joy Dela Peña I; Kim M; Woo T; Kim HJ; Kim HI; Chang Cho M; Lee YS; Cheong JH Neuropharmacology; 2017 Nov; 126():121-127. PubMed ID: 28867363 [TBL] [Abstract][Full Text] [Related]
12. [A reviewing for abusing of ketamine]. Yang J; Bian SZ Fa Yi Xue Za Zhi; 2007 Aug; 23(4):312-5. PubMed ID: 17896530 [TBL] [Abstract][Full Text] [Related]
13. Ketamine-like effects after recreational use of methoxetamine. Hofer KE; Grager B; Müller DM; Rauber-Lüthy C; Kupferschmidt H; Rentsch KM; Ceschi A Ann Emerg Med; 2012 Jul; 60(1):97-9. PubMed ID: 22237166 [TBL] [Abstract][Full Text] [Related]
14. Ketamine: The final frontier or another depressing end? Sial OK; Parise EM; Parise LF; Gnecco T; Bolaños-Guzmán CA Behav Brain Res; 2020 Apr; 383():112508. PubMed ID: 32017978 [TBL] [Abstract][Full Text] [Related]
15. Ketamine: repurposing and redefining a multifaceted drug. Potter DE; Choudhury M Drug Discov Today; 2014 Dec; 19(12):1848-54. PubMed ID: 25224017 [TBL] [Abstract][Full Text] [Related]
16. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings. Zanda MT; Fadda P; Chiamulera C; Fratta W; Fattore L Behav Pharmacol; 2016 Sep; 27(6):489-96. PubMed ID: 27128862 [TBL] [Abstract][Full Text] [Related]
17. The ketamine analog methoxetamine: a new designer drug to threaten military readiness. Craig CL; Loeffler GH Mil Med; 2014 Oct; 179(10):1149-57. PubMed ID: 25269134 [TBL] [Abstract][Full Text] [Related]
19. Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential. Botanas CJ; de la Peña JB; Dela Peña IJ; Tampus R; Yoon R; Kim HJ; Lee YS; Jang CG; Cheong JH Pharmacol Biochem Behav; 2015 Jun; 133():31-6. PubMed ID: 25792291 [TBL] [Abstract][Full Text] [Related]
20. New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT Marti M; Talani G; Miliano C; Bilel S; Biggio F; Bratzu J; Diana M; De Luca MA; Fattore L Exp Neurol; 2021 Nov; 345():113836. PubMed ID: 34384790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]